Consult your healthcare provider before using if pregnant or nursing
It Is a once-a-week subcutaneous injection administered under the skin of your stomach, the outer part of the upper thigh, or the upper arm with or without food
On the one hand, it down-regulates the expression of sterol regulatory element-binding protein 1c and its downstream fatty acid synthase and acetyl-CoA carboxylase 1, thereby inhibiting de novo lipid synthesis in the liver from the source
A number of studies have shown that GLP-/GIPR dual agonists can achieve better blood glucose control, insulin sensitivity, lipid metabolism and weight loss compared with GLP-1 alone [136,137]
Epidemiology More than seventy patients have been reported in more than 50 families worldwide
Inositol and choline further enhance this process by contributing to lipid transport and energy regulation within cells